ACTO

DECEMBER 17, 2024

The stakes for AI adoption in the pharmaceutical industry have never been higher. Yet, the critical question remains: How can pharmaceutical companies ensure responsible and compliant AI implementation while maximizing its potential for field teams?

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52

Drug Patent Watch

MARCH 18, 2025

Exploring the Russian Pharma Industry: Key Players and Innovations As we continue to navigate the complexities of the global pharmaceutical landscape, it's essential to stay informed about emerging markets and trends. With the Russian government's support for domestic production, biosimilars are becoming increasingly important in the country.

Biosimilars 88

Biosimilars Pharmaceutical Companies Government Pharmaceuticals 88

Drug Channels

MARCH 29, 2021

Medicaid and Government Pricing Congress. The Medicaid and Government Pricing Congress , an important event dedicated to critical policy updates and approaches to effectively contract, report and comply with state and federal healthcare programs, returns June 8-11, 2021. More Interaction.

Government 52

Government Pharmacy Pharmaceuticals Production 52

FDA Law Blog: Biosimilars

JUNE 12, 2024

HP&M) seeks to add an experienced attorney (7+ years) to our government discount program and price reporting practice. Hyman, Phelps & McNamara, P.C. (HP&M) Our firm culture is collaborative, and the subject matter is intellectually stimulating. Strong verbal and writing skills are required.

Government 59

Government FDA Pharmaceuticals Drugs 59

Drug Channels

MARCH 29, 2021

Medicaid and Government Pricing Congress. The Medicaid and Government Pricing Congress , an important event dedicated to critical policy updates and approaches to effectively contract, report and comply with state and federal healthcare programs, returns June 8-11, 2021. More Interaction.

Government 52

Government Pharmacy Pharmaceuticals Production 52

The Pharma Data

SEPTEMBER 15, 2020

A joint letter co-signed by the Royal Pharmaceutical Society, the British Medical Association, the Royal College of GPs, patient group National Voices and others has called for the UK government to change the law regarding pharmacists’ powers to alter prescriptions.

Government 52

Government Pharmaceuticals 52

Drug Patent Watch

DECEMBER 10, 2024

Government initiatives: Both countries have implemented policies to address patent thicket issues and promote innovation. Compulsory licensing: India has used compulsory licensing to address patent thicket issues in critical areas like pharmaceuticals.

Licensing 98

Licensing Licensing International Marketing 98

The Pharma Data

DECEMBER 19, 2020

government and other private-sector companies such as Moderna to support in the distribution of COVID-19 vaccines and the ancillary supply kits. government. McKesson has a long history of managing the pharmaceutical and medical supply chain in the U.S., A worker at McKesson’s Olive Branch, Miss. The U.S.

Government 52

Government Vaccine Pharmacy Pharmaceuticals 52

The Pharma Data

AUGUST 4, 2020

The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure the coronavirus pandemic has had on their current stockpiles. The government wants to sure up supplies for the general population as well as the National Health Service. Photo by Rennett Stowe.

Government 52

Government Drugs Pharmaceuticals Production 52

The Pharma Data

AUGUST 31, 2020

Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate. MONTRÉAL, QC – August 31, 2020 – Janssen Inc., Source link.

Government 52

Government Vaccine Pharmaceutical Companies Clinical Trials 52

The Pharma Data

JULY 15, 2021

– Victorian State Government extends financing of JJIPO@Monash for an additional two years. Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University’s Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.

Government 52

Government Science Pharmaceuticals Pharmaceutical Companies 52

LifeSciVC

MAY 14, 2025

At the molecular level, gravity underlies sedimentation and convection, the central principles that govern fluid dynamics. 1,2,3 Among a long list of innovations, the lowest hanging fruit for commercialization is the use of microgravity-based crystallization to enhance high-value pharmaceuticals.

Science 95

Science Production Research Drugs 95

The Pharma Data

AUGUST 14, 2020

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of their vaccine candidates to protect against COVID-19 infection. . S, the COVID-19 vaccine candidate developed by Janssen, the pharmaceutical subsidiary of J&J, for not-for-profit emergency pandemic use.

Government 52

Government Vaccine Clinical Trials Therapies 52

The Pharma Data

AUGUST 5, 2020

Government for 100 Million Doses of Investigational COVID-19 Vaccine. Government for 100 Million Doses of Investigational COVID-19 Vaccine. August 05, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. New Brunswick, N.J.,

Government 52

Government Vaccine Pharmaceutical Companies Pharmaceuticals 52

Pharmaceutical Development Group

AUGUST 9, 2021

Formulation chemistry is the systematic and step-by-step approach to pharmaceutical development. Nowadays, as the usage of medicines is increasing, pharmaceutical companies are more eager to bring manufacturing a new look in quality and performance. There are different tests to assess the quality of a pharmaceutical product.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies FDA Approval Production 52

FDA Law Blog: Biosimilars

APRIL 7, 2025

Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institutes 23rd Advanced Summit on Life Sciences Patents , which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, NY.

Science 59

Science Government FDA Pharmaceuticals 59

thought leadership

APRIL 4, 2025

The US Government recently modified their policy to utilize tariffs to in an effort to support the US economy. Pharmaceutical tariffs of 25% have been forecasted causing many global organizations to investigate the consequences of the tariffs on their overall product portfolio.

Pharmaceuticals 52

Pharmaceuticals Regulations Government Production 52

DrugBank

JANUARY 22, 2025

Environmental Impacts of Traditional Pharmaceutical Production Traditional pharmaceutical manufacturing is complex, with each phase contributing to environmental degradation. The extraction and synthesis of active pharmaceutical ingredients (API) utilize vast amounts of water and energy.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Production Government 52

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. healthcare spending. Click here to see the original post from April 2022. spending on healthcare.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

FDA Law Blog: Biosimilars

MAY 15, 2025

Against the backdrop of increasing uncertainty and change in the drug pricing landscape, this hybrid event brings together experts working in or with the pharmaceutical and biotechnology industries to share best practices and discuss the cross-functional impacts of the ever-changing government and state drug pricing landscape on commercialization, (..)

Science 59

Science Government Compliance FDA 59

FDA Law Blog: Biosimilars

DECEMBER 4, 2023

Federal Court Orders Puerto Rico Pharmaceutical Distributor to Pay $12 Million in Connection with Alleged Failure to Report Suspicious Orders of Pharmaceutical Drugs and Other Controlled Substance Violations, Nov. The government asserted additional allegations that are outside our scope. 6, 2023 ( DOJ Press Release ).

Pharmacy 139

Pharmacy Government Treatment Compliance 139

Drug Channels

APRIL 12, 2022

Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. One bright spot: consumers will account for an ever-smaller share of drug spending. healthcare spending growth. to 1:30 p.m.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

The Premier Consulting Blog

OCTOBER 30, 2024

In recent years, advanced manufacturing has gained traction in the pharmaceutical industry, transforming how drugs are developed, produced, and delivered. 3D printing (additive manufacturing) : In the pharmaceutical sector, 3D printing allows for personalized medicine by creating precise dosages and unique drug delivery systems.

FDA 52

FDA Regulations Pharmaceuticals Production 52

Drug Patent Watch

APRIL 1, 2025

The Biosimilar Revolution: How Europe's Generic Drug Industry is Evolving As we navigate the ever-changing landscape of the pharmaceutical industry, one trend is clear: biosimilars are here to stay. As healthcare costs continue to rise, governments and payers are looking for ways to reduce expenses without compromising patient outcomes.

Biosimilars 77

Biosimilars Marketing Drugs Government 77

Drug Channels

APRIL 8, 2024

We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

DrugBank

APRIL 25, 2024

As the pharmaceutical industry is pushing to deliver new and better drugs while racing against time and budget constraints, it is becoming crucial to not just use artificial intelligence (AI) but truly maximize its potential. Invest in Your Tech Infrastructure A solid tech foundation is essential for AI to work in the pharmaceutical sector.

Clinical Trials 98

Clinical Trials Regulations Compliance Government 98

The Pharma Data

NOVEMBER 18, 2020

Hal came to the pharmaceutical business at mid-career, age 39. After his government work, Hal seized an opportunity to help build a new, not-for-profit organization, Family Planning International Assistance (FPIA), in New York City. This work took him to some 50 countries and allowed Hal to meet pharmaceutical business leaders.

Pharmaceuticals 52

Pharmaceuticals International Engineering Government 52

The Pharma Data

AUGUST 5, 2020

5, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. government may also purchase an additional 200 million doses of Ad26.COV2.S

Government 40

Government Vaccine Pharmaceutical Companies Pharmaceuticals 40

Advarra

AUGUST 8, 2024

We also summarize the key information pharmaceutical companies and contract research organizations (CROs) need to know to prepare for compliance. This article explores the likely impact of the AI Act on software and systems used in clinical research and how it affects entities outside the EU.

Clinical Research 98

Clinical Research Research Clinical Trials Compliance 98

Advarra

MARCH 6, 2025

Over the years, Advarra has reviewed a wide range of clinical research studies and worked every day alongside leading pharmaceutical manufacturers, medical researchers, and healthcare institutions. Advarra draws members from leading academic institutions, government agencies, and clinical research organizations.

Clinical Research 52

Clinical Research Research Clinical Trials Bioethics 52

DrugBank

DECEMBER 18, 2024

A new shift is occurring in the pharmaceutical industry, leading to a rapidly expanding field known as digital therapeutics (DTx). DTx interventions include sensor-equipped wearable devices, remote patient monitoring tools, and virtual reality platforms integrated with conventional pharmaceutical treatments.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Treatment Therapies 52

Drug Channels

MARCH 19, 2023

Featured Faculty Driving the Conversation: Rosalind Davis, Government Pricing & Contracts Director , Vifor Pharma, Inc. Attendees of Commercial Contracts & Chargebacks 2023 have the option to add a third day of content to their schedule and join the Medicaid & Government Pricing Congress attendees for their final day.

Science 75

Science Government Pharmaceuticals Drugs 75

Drug Channels

SEPTEMBER 20, 2021

View the agenda to see the complete picture – agenda, speakers, and more! Plus, in-person participation qualifies for CPE credits!

Pharmaceuticals 93

Pharmaceuticals Production Government Science 93

Broad Institute

NOVEMBER 2, 2023

Our joint goal is to bring innovation to cancer patients by building a robust, sustainable pipeline in oncology,” said Dominik Ruettinger, Global Head of Research and Early Development for Oncology, Pharmaceuticals Division, Bayer AG. The research is guided by joint project and governance teams.

Therapies 105

Therapies Research Small Molecule Clinical Trials 105

Drug Patent Watch

FEBRUARY 18, 2025

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the fight against high healthcare costs.

Biosimilars 55

Biosimilars Trials Clinical Trials Production 55

Drug Channels

JULY 11, 2022

President and CEO, National Pharmaceutical Council Julie Ritchie Wagner, Senior Assistant General Counsel, Head of Global Ethics, Compliance, and Enforcement Legal Policy, PhRMA Joel White, Founder and President, Horizon Government Affairs Charlene Keller Fullmer, Assistant U.S. O’Brien, Pharm.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Compliance 98

ACTO

DECEMBER 17, 2024

The stakes for AI adoption in the pharmaceutical industry have never been higher. Yet, the critical question remains: How can pharmaceutical companies ensure responsible and compliant AI implementation while maximizing its potential for field teams?

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52